Tueday 2nd October will see the Institute for Bioengineering of Catalonia’s 11th Annual Symposium take place at Barcelona’s AXA Auditoritum, the first symposium in the insitute’s second decade of activity.
Focusing this year on the topic of Bioengineering for Regenerative Therapies – one of IBEC’s three areas of application, with its expertise in 3D bioprinting, biomaterials, nanomedicine, stem cells and biomechanics – the symposium will welcome expert speakers in tissue engineering and regeneration from all over the world.
|Prof. Ron Weiss, Professor of Biological Engineering at MIT, is one of the pioneers of synthetic biology. He has been engaged in synthetic biology research since 1996 when he was a graduate student at MIT and where he helped set up a wet-lab in the Electrical Engineering and Computer Science Department. After completion of his PhD, Weiss joined the faculty at Princeton University, and recently returned to MIT to take on a tenured faculty position in the Department of Biological Engineering and the Department of Electrical Engineering and Computer Science. (Speaking at 17:25pm)|
|Prof. Frank Baaijens serves as Rector Magnificus at Eindhoven University of Technology (TU/e). A full professor of Soft Tissue Biomechanics and Tissue Engineering, his focus is building on the TU/e’s strengths with the entire community, strengthening the university’s international position and working on finding solutions to current and future societal challenges, bridging education and research. (Speaking at 12:15pm)|
|Dr. Didier Letourneur is the Director of the Laboratory for Vascular Translational Science (with about 220 people) affiliated to INSERM and the universities Paris Diderot and Paris North. He also leads the team of Cardiovascular Bioengineering at Bichat Hospital. In 2016, he found the company SILTISS to develop of innovative implants from polysaccharide-based materials, and is President of BIOMAT, the French Society for Biomaterials. (Speaking at 15:25pm)|
Our branding for the symposium this year pays tribute to Mary Shelley’s ‘Frankenstein, or the Modern Prometheus’, one of the most famous novels in the English language. When it was published two hundred years ago, the concept of bioengineering was unknown, and biology and medicine were only starting to progress with the first detailed studies of the cardiovascular system and experiments with blood transfusions.
Today, bioengineering –encompassing micromachines and robotics, genetic testing, implants, tissue regeneration and stem cell research – promises still more groundbreaking advances in health care and quality of life through genetic tests, prosthetic limbs and organ implants, as well as in research into cancer, nutrition, the human genome, transgenics, gene editing, and countless other areas.
More information at https://events.ibecbarcelona.eu/symposium2018/